getting treated for depression
The number of people treated for depression has increased dramatically, most likely due to reduced stigma about mental health problems as well as the availability of new medications, according to a School of Medicine researcher.
The study, published in the Jan. 9 issue of the Journal of the American Medical Association, was based on two large national surveys and looked at outpatient treatment for depression between 1987 and 1997. The researchers found that the number of people seeking help more than tripled, from 0.7% to 2.3%, says Dr. Benjamin Druss, professor in the Departments of Psychiatry and Epidemiology and Public Health.
The findings probably indicate that more people are getting treatment for depression rather than a change in prevalence of depression, notes Druss. "Recent years have seen both a reduction of the stigma associated with seeking care for depression, and also broader changes in the organization of medicine," he says. "The changes also likely reflect the development of new classes of antidepressants that are relatively easy to use and can be prescribed in primary care settings. The first of these newer medications, Prozac, was released soon after the study began."
The proportion of individuals who used antidepressant medications increased from 37.3% to 74.5% while the number of people who received psychotherapy declined from 71.1% to 60.2%, according to the findings. Also, an increasingly larger proportion of patients were treated by physicians for their condition and treatment costs were more often covered by third-party payers.
"The increase is almost certainly a good thing because the rates of treatment for depression are so low relative to the disease's prevalence in the community," Druss says. "But we need a better understanding of whether this increase has occurred in patients with more severe depression or whether it is largely being used in patients with less serious or transient conditions. We also need to know more about the quality of care received by patients who receive treatment."
The lead author was Mark Olfson, associate professor of clinical psychiatry at Columbia University and the New York State Psychiatric Institute.
-- By Jacqueline Weaver
T H I S
Bulletin Home
W E E K ' SS T O R I E S
Yale and Unions agree to seek more effective negotiations process
Campus events honor legacy of Martin Luther King Jr.
Center receives over $12 million in grants for research on AIDS
IN FOCUS: Electrical Engineering
'Painted Ladies' of king's court featured in exhibition
MEDICAL SCHOOL NEWSCarolyn Mazure named associate dean for faculty affairs
Research reveals that quitting smoking impairs some cognitive . . .
Tamborlane to head national project on juvenile diabetes
Study: More people now getting treated for depression
Medical students donating proceeds from show . . .
Brain abscess case linked to tongue piercing
'Art for All Seasons' showcases works by Asian artists
Works depict the human form, both draped and undraped
'A Streetcar Named Desire' comes to the Yale stage
Petrarch's poetry will be highlighted in a campus talk . . .
Symposium to examine roots of modern visual culture
Woodcut offers panoramic view of 16th-century Muslim life
OBITUARIESEnglish Professor Louis Martz: 'One of Yale's great teachers'
George Goold: Chief editor of Loeb Classical Library series
Dr. Ruth Whittemore: Noted pediatric cardiologist
Faith Hubley: Academy Award-winning animator and filmmaker
Memorial service for Naomi Schor
Funny things will happen during a Roman-style comedy week
Standing, Special and Appointments Committees
Yale seeks nominees for 2001 Seton Elm-Ivy Awards
Fellowships for foreign study and travel offered by YCIAS
Yale Books in Brief
Campus Notes
|Visiting on Campus|Calendar of Events|In the News|Bulletin Board
Yale Scoreboard|Classified Ads|Search Archives|Deadlines
Bulletin Staff|Public Affairs Home|News Releases|
E-Mail Us|Yale Home Page